Knight Therapeutics Inc. (TSX:GUD) NDS for GEMTESA Accepted by Health Canada
Knight Therapeutics said Health Canada accepted its New Drug Submission for GEMTESA for overactive bladder, including adult males on BPH pharmacotherapy.Material DetailsContext by AI AnalystThis is an early regulatory milestone in Knight’s Canadian rollout of in-licensed therapies from Sumitomo. A…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.